Bibliography
Found 1068 results
CSF markers of AD-related pathology relate specifically to memory impairment in older people with HIV: a pilot study. J Neurovirol. 2022 ;28(1):162-167.
. Development of Droplet Digital PCR-Based Assays to Quantify HIV Proviral and Integrated DNA in Brain Tissues from Viremic Individuals with Encephalitis and Virally Suppressed Aviremic Individuals. Microbiol Spectr. 2022 ;10(1):e0085321.
. DNA methylation clocks for dogs and humans. Proc Natl Acad Sci U S A. 2022 ;119(21):e2120887119.
Ethnic/Racial Disparities in Longitudinal Neurocognitive Decline in People With HIV. J Acquir Immune Defic Syndr. 2022 ;90(1):97-105.
Functional Compartmentalization of Antibodies in the Central Nervous System During Chronic HIV Infection. J Infect Dis. 2022 ;226(4):738-750.
Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid. J Neurovirol. 2022 ;28(2):281-290.
Higher Comorbidity Burden Predicts Worsening Neurocognitive Trajectories in People with Human Immunodeficiency Virus. Clin Infect Dis. 2022 ;74(8):1323-1328.
. Identification of Youthful Neurocognitive Trajectories in Adults Aging with HIV: A Latent Growth Mixture Model. AIDS Behav. 2022 ;26(6):1966-1979.
Intraneuronal β-Amyloid Accumulation: Aging HIV-1 Human and HIV-1 Transgenic Rat Brain. Viruses. 2022 ;14(6).
. Neuropathic pain correlates with worsening cognition in people with human immunodeficiency virus. Brain. 2022 ;145(6):2206-2213.
. Neuropathologic Findings in Elderly HIV-Positive Individuals. J Neuropathol Exp Neurol. 2022 ;81(7):565-576.
Peripheral inflammation and depressed mood independently predict neurocognitive worsening over 12 years. Brain Behav Immun Health. 2022 ;21:100437.
Acrolein and other toxicant exposures in relation to cardiovascular disease among marijuana and tobacco smokers in a longitudinal cohort of HIV-positive and negative adults. EClinicalMedicine. 2021 ;31:100697.
Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV. J Neurovirol. 2021 ;27(1):160-167.
HIV disease duration, but not active brain infection, predicts cortical amyloid beta deposition. AIDS. 2021 ;35(9):1403-1412.
. Lentiviral Infections Persist in Brain despite Effective Antiretroviral Therapy and Neuroimmune Activation. mBio. 2021 ;12(6):e0278421.
The Longitudinal Effects of Blood Pressure and Hypertension on Neurocognitive Performance in People Living with HIV. J Acquir Immune Defic Syndr. 2021 .
. Multimorbidity networks associated with frailty among middle aged and older people with HIV. AIDS. 2021 .
. Neurocognitive status and risk of mortality among people living with human immunodeficiency virus: an 18-year retrospective cohort study. Sci Rep. 2021 ;11(1):3738.
. Physical and Mental Health Screening in a New York City HIV Cohort During the COVID-19 Pandemic: A Preliminary Report. J Acquir Immune Defic Syndr. 2021 ;86(3):e54-e60.
. . Antiretroviral Penetration and Drug Transporter Concentrations in the Spleens of Three Preclinical Animal Models and Humans. Antimicrob Agents Chemother. 2020 ;64(10).
Assessing Cognitive Functioning in People Living With HIV (PLWH): Factor Analytic Results From CHARTER and NNTC Cohorts. J Acquir Immune Defic Syndr. 2020 ;83(3):251-259.
. Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy. AIDS. 2020 ;34(7):1001-1007.
. Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV. J Acquir Immune Defic Syndr. 2020 ;83(1):56-64.
.